You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Laboratory Sciences Preclinical Evaluation of the Novel Small-Molecule Integrin 5β1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization
Grit Zahn; Dörte Vossmeyer; Roland Stragies; Margaret Wills; Corinne G. Wong; Karin U. Löffler; Anthony P. Adamis; Jochen Knolle
Arch Ophthalmol 2009; 127: 1329-1335.
[Abstract][Full text][PDF]
Small Case Series Clinical and Tomographic Features of Macular Punctate Outer Retinal Toxoplasmosis
Eduardo Cunha de Souza; Antonio M. B. Casella
Arch Ophthalmol 2009; 127: 1390-1394.
[Extract][Full text][PDF]
Past content
(since Feb 1998):
Clinical Trials A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5
Clinical Trials A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6
Socioeconomics and Health Services A Perspective on Commercial Relationships Between Ophthalmology and Industry
Lee M. Jampol; Samuel Packer; Richard P. Mills; Susan H. Day; Paul R. Lichter; for the Council of the American Ophthalmological Society
Arch Ophthalmol 2009; 127: 1194-1202.
[Abstract][Full text][PDF]
Editorials SCOREing in Retinal Venous Occlusive Disease
Surgical Techniques Management of Fluocinolone Implant Dissociation During Implant Exchange
Steven Yeh; Colleen M. Cebulla; S. Robert Witherspoon; Geoffrey G. Emerson; M. Vaughn Emerson; Eric B. Suhler; Thomas A. Albini; Christina J. Flaxel
Arch Ophthalmol 2009; 127: 1218-1221.
[Abstract][Full text][PDF]
Letters Response to Editorial About the Convergence Insufficiency Treatment Trial
Susan Cotter; Marjean Kulp; Mitchell Scheiman; Richard Hertle; G. Lynn Mitchell; Michael Rouse; for the Convergence Insufficiency Treatment Trial (CITT) Executive Committee
Arch Ophthalmol 2009; 127: 1229-a-1230-a.
[Extract][Full text][PDF]